CAS: 1655504-04-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide REF: AN-AG01KFHUCAS: 1655504-04-3 | 98% | 187,00 €~607,00 € | Vie 07 Jun 24 |
 | Orelabrutinib REF: TM-T12317CAS: 1655504-04-3 | 99.44% | 89,00 €~1.859,00 € | Vie 07 Jun 24 |
 | Orelabrutinib REF: 3D-FRC50404CAS: 1655504-04-3 | Min. 95% | 106,00 €~592,00 € | Lun 17 Jun 24 |
![6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide](https://static.cymitquimica.com/products/AN/thumb/AG01KFHU.jpg)
6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide
CAS:1655504-04-3
Fórmula:
C26H25N3O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
427.4950
Ref: AN-AG01KFHU
| 25mg | 187,00 € | ||
| 50mg | 224,00 € | ||
| 100mg | 506,00 € | ||
| 250mg | 607,00 € |
Entrega estimada en Estados Unidos, el Viernes 7 de Junio de 2024
Orelabrutinib
CAS:1655504-04-3
Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).
Fórmula:
C26H25N3O3
Pureza:
99.44%
Forma y color:
Solid
Peso molecular:
427.49
Ref: TM-T12317
| 1mg | 89,00 € | ||
| 5mg | 184,00 € | ||
| 10mg | 309,00 € | ||
| 25mg | 511,00 € | ||
| 50mg | 707,00 € | ||
| 100mg | 925,00 € | ||
| 500mg | 1.859,00 € | ||
| 1ml*10 (DMSO) | 212,00 € |
Entrega estimada en Estados Unidos, el Viernes 7 de Junio de 2024
Orelabrutinib
CAS:1655504-04-3
Orelabrutinib is a potent inhibitor of Bruton's tyrosine kinase (BTK). It has been shown to …
Fórmula:
C26H25N3O3
Pureza:
Min. 95%
Peso molecular:
427.5 g/mol
Ref: 3D-FRC50404
| 5mg | 106,00 € | ||
| 10mg | 157,00 € | ||
| 25mg | 283,00 € | ||
| 50mg | 399,00 € | ||
| 100mg | 592,00 € |
Entrega estimada en Estados Unidos, el Lunes 17 de Junio de 2024
